Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: Study protocol for a phase II randomised controlled trial
Dena R. Howard, Talha Munir, Anna Hockaday, Andy C. Rawstron, Laura Collett, Jamie B. Oughton, David Allsup, Adrian Bloor, David Phillips, Peter Hillmen
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: Study protocol for a phase II randomised controlled trial'. Together they form a unique fingerprint.